Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
5.36
+0.02 (0.37%)
At close: Apr 28, 2026, 4:00 PM EDT
5.37
+0.01 (0.19%)
After-hours: Apr 28, 2026, 4:47 PM EDT
Abeona Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Abeona Therapeutics stock have an average target of 20, which predicts an increase of 273.13% from the current stock price of 5.36.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 19, 2026.
Analyst Ratings
The average analyst rating for Abeona Therapeutics stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 3 | 3 | 3 | 3 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +273.13% | Mar 19, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +273.13% | Mar 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +273.13% | Oct 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +273.13% | Aug 18, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $19 → $20 | Buy | Maintains | $19 → $20 | +273.13% | Aug 15, 2025 |
Financial Forecast
Revenue This Year
65.44M
from 5.82M
Increased by 1,024.31%
Revenue Next Year
160.59M
from 65.44M
Increased by 145.42%
EPS This Year
-0.82
from 1.01
EPS Next Year
0.20
from -0.82
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 103.8M | 197.5M | ||||||
| Avg | 65.4M | 160.6M | ||||||
| Low | 41.5M | 134.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1,683.8% | 201.8% | ||||||
| Avg | 1,024.3% | 145.4% | ||||||
| Low | 612.7% | 105.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.44 | 0.66 | ||||||
| Avg | -0.82 | 0.20 | ||||||
| Low | -1.12 | -0.46 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.